AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

CSL LIMITED

168.300

-2.900-1.69%

Volume:2.69M

Turnover:422.09M

Market Cap:80.60B

PE:-22.55

High:171.535

Open:170.000

Low:166.280

Close:171.200

52wk High:219.589

52wk Low:90.000

Shares:478.91M

Float Shares:478.91M

Volume Ratio:1.02

T/O Rate:0.56%

Dividend:4.07

Dividend Rate:2.42%

EPS(TTM):-7.465

EPS(LYR):-7.465

ROE:-15.83%

ROA:7.26%

PB:3.90

PE(LYR):-22.55

Loading ...

Overview Company News Filings

Australia's CSL plunges on outlook cut, $5 billion impairment warning

BRIEF-CSL Expects FY26 Revenue $15.2 Bln, NPATA $3.1 Bln At Constant Currency

CSL Cuts Annual Guidance, Signals $5 Billion of New Impairments -- Update

Australia's CSL cuts 2026 earnings forecast as payoff from growth initiatives delayed

CSL Ltd - Expects $300 Mln FY26 Revenue Impact From U.S. Immunoglobulin Channel Inventory Normalisation

THOMSON REUTERS

CSL Ltd-Interim CEO 90 Day Review and Financial Update

THOMSON REUTERS

CSL Ltd - Expects FY26 Revenue of $15.2 Bln and Npata of $3.1 Bln Constant Currency

THOMSON REUTERS

How CSL’s Share Buyback and Seqirus Demerger Plan Will Impact CSL (ASX:CSL) Investors

Simply Wall St.

A Look At CSL (ASX:CSL) Valuation After Seqirus Demerger Plan CEO Exit And Ongoing Share Price Weakness

Simply Wall St.

Sprout Social Q1 revenue slightly beats estimates

Australian Dollar Reaches Four-Year Peak: Which ASX Stocks Stand to Gain?

FACTBOX-Global drugmakers rush to boost US presence as tariff threat looms

Market Chatter: CSL, Resmed, Cochlear Lead Losses on ASX

MT Newswires Live

Will Restructuring Moves and Seqirus Spin-Off Delay Change CSL's (ASX:CSL) Investment Narrative?

Simply Wall St.

A Fresh Look At CSL (ASX:CSL) Valuation After Recent Share Price Weakness

Simply Wall St.

CSL Finance Raises INR300 Million Through Allotment of Non-Convertible Debentures

MT Newswires Live

Carlisle Companies Q1 Margin Pullback Tests Long Term Expansion Thesis

Simply Wall St.

Eurazeo unit Kurma Partners closes Biofund IV at EUR 215 million

Australian shares close at two-week low on oil price concerns; Santos jumps over 3%

BUZZ-Australia's CSL hits 9-year low after US scraps mandatory flu vaccines for military

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/CSL.AU/news?page=10"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CSL.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CSL.AU\",,,,,undefined,":{"symbol":"CSL.AU","market":"AU","secType":"STK","nameCN":"CSL LIMITED","latestPrice":168.3,"timestamp":1787292720000,"preClose":171.2,"halted":0,"volume":2686531,"delay":0,"changeRate":-0.016939252336448468,"nameEN":"CSL LIMITED","floatShares":478911979,"shares":478911979,"eps":-7.464769080507883,"marketStatus":"Not Yet Opened","change":-2.9,"latestTime":"08-21 16:12:00 AEST","open":170,"high":171.535,"low":166.28,"amount":422094220,"amplitude":0.030695,"askPrice":168.48,"askSize":108,"bidPrice":168,"bidSize":5,"shortable":3,"etf":0,"ttmEps":-7.464769080507883,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1787529600000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":171.2,"dividendRate":0.024373,"openAndCloseTimeList":[[1787270400000,1787292000000]],"volumeRatio":1.0181516551769705,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"CSL.AU","preClose":171.2,"auctionPrice":168.34,"auctionVolume":585682,"auction":3,"marketStatus":"盘后竞价","timestamp":1787292600245}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CSL.AU\",,,,,undefined,":{"symbol":"CSL.AU","floatShares":478911979,"roa":"7.26%","roe":"-15.83%","lyrEps":-7.464769,"volumeRatio":1.0181516551769705,"shares":478911979,"dividePrice":4.074229,"high":171.535,"amplitude":0.030695,"preClose":171.2,"low":166.28,"week52Low":90,"pbRate":"3.90","psRate":"3.66","week52High":219.589,"institutionHeld":0,"latestPrice":168.3,"committee":-0.911504,"eps":-7.464769080507883,"divideRate":0.024208,"volume":2686531,"delay":0,"ttmEps":-7.464769080507883,"open":170,"prevYearClose":170.408,"prevWeekClose":168.3,"prevMonthClose":123.06,"prevQuarterClose":114.74,"fiveDayClose":136.5,"twentyDayClose":114.22,"sixtyDayClose":97.59,"dividendPayoutRate":0.4488044711953849,"dividendGrowthYears":5,"dividendGrowthRate":0.003543182641490467,"fiveYearAvgDividendRate":0.018567360626050477},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CSL.AU\",params:#limit:5,,,undefined,":[{"date":"2026-09-09","symbol":"CSL.AU","amount":1.62,"announcedDate":"2026-08-18","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2026-09-10","defaultRemindTime":1788912000000,"name":"CSL LIMITED","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-10-02","payableDate":"2026-09-10","currency":"USD","dateTimestamp":1788876000000,"payDate":"2026-10-02"},{"date":"2026-08-18","symbol":"CSL.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787011200000,"name":null,"time":"","dateTimestamp":1786975200000,"actualEps":null},{"date":"2026-03-10","symbol":"CSL.AU","amount":1.3,"announcedDate":"2026-02-11","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2026-03-11","name":"CSL LIMITED","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-04-09","payableDate":"2026-03-11","currency":"USD","dateTimestamp":1773061200000,"payDate":"2026-04-09"},{"date":"2026-02-11","symbol":"CSL.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1770764400000,"name":null,"time":"","dateTimestamp":1770728400000,"actualEps":null},{"date":"2025-09-09","symbol":"CSL.AU","amount":1.62,"announcedDate":"2025-08-19","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-09-10","defaultRemindTime":1757376000000,"name":"CSL LIMITED","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-10-03","payableDate":"2025-09-10","currency":"USD","dateTimestamp":1757340000000,"payDate":"2025-10-03"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CSL.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2020-09-10","recordDate":"2020-09-11","paymentDate":"2020-10-09","value":1.469578,"currency":"AUD"},{"executeDate":"2021-03-04","recordDate":"2021-03-05","paymentDate":"2021-04-01","value":1.04,"currency":"USD"},{"executeDate":"2021-09-02","recordDate":"2021-09-03","paymentDate":"2021-09-30","value":1.062,"currency":"USD"},{"executeDate":"2022-03-07","recordDate":"2022-03-08","paymentDate":"2022-04-06","value":1.04,"currency":"USD"},{"executeDate":"2022-09-06","recordDate":"2022-09-07","paymentDate":"2022-10-05","value":1.062,"currency":"USD"}],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CSL.AU\",pageSize:20,pageCount:10,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2634424446","title":"Australia's CSL plunges on outlook cut, $5 billion impairment warning","url":"https://stock-news.laohu8.com/highlight/detail?id=2634424446","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634424446?lang=en_us&edition=fundamental","pubTime":"2026-05-11 07:09","pubTimestamp":1778454555,"startTime":"0","endTime":"0","summary":"UPDATE 5-Australia's CSL plunges on outlook cut, $5 billion impairment warningCSL flags $5 billion in impairments across 2026-2027Shares plunge to lowest level since early 2017Vifor deal underperforms, weighs on turnaroundAdds closing share price moves for CSL in paragraph 2By Rajasik Mukherjee and Roushni Nair","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260510:nL1N41N067:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","BK7067","BK7508","BK7511","CSL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634424681","title":"BRIEF-CSL Expects FY26 Revenue $15.2 Bln, NPATA $3.1 Bln At Constant Currency","url":"https://stock-news.laohu8.com/highlight/detail?id=2634424681","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634424681?lang=en_us&edition=fundamental","pubTime":"2026-05-11 06:46","pubTimestamp":1778453168,"startTime":"0","endTime":"0","summary":"BRIEF-CSL Expects FY26 Revenue $15.2 Bln, NPATA $3.1 Bln At Constant CurrencyMay 11 (Reuters) - CSL Ltd CSL.AX:INTERIM CEO 90 DAY REVIEW AND FINANCIAL UPDATEEXPECTS $300 MILLION FY26 REVENUE IMPACT FR","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260510:nTUE3S3DVB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","BK7511","BK7501","CSL.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634245994","title":"CSL Cuts Annual Guidance, Signals $5 Billion of New Impairments -- Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2634245994","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634245994?lang=en_us&edition=fundamental","pubTime":"2026-05-11 06:43","pubTimestamp":1778452980,"startTime":"0","endTime":"0","summary":"SYDNEY--Pharmaceutical company CSL on Monday downgraded its annual earnings guidance and signaled another $5 billion of pretax impairments, including for the Vifor business that it acquired for $11.7 billion in 2022.CSL said it now expects revenue of around $15.2 billion and an underlying net profit of $3.1 billion in the 12 months through June when currency swings are stripped out. The net profit measure, known as Npata, excludes restructuring costs and impairment charges.In February, CSL had forecast Npata growth of 4-7% excluding one-off costs at constant currency and  revenue growth of 2-3%.\"Our growth initiatives are working, but the financial benefits will take longer than previously anticipated to materialize,\" said Gordon Naylor, CSL's interim chief executive. \"As a result, we have now revised down our 2026 financial year guidance.\". CSL said demand for immunoglobulin in the U.S. is growing at mid-to-single digit percent, which is consistent with its own expectations. However, ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSL.AU","SG9999004303.SGD","BK7511","BK7067","BK7501","CSL","BK4086","LU1169590202.USD","LU1169589451.USD","LU0728928796.USD","BK7508","SGXZ23171101.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634341424","title":"Australia's CSL cuts 2026 earnings forecast as payoff from growth initiatives delayed","url":"https://stock-news.laohu8.com/highlight/detail?id=2634341424","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634341424?lang=en_us&edition=fundamental","pubTime":"2026-05-11 06:37","pubTimestamp":1778452670,"startTime":"0","endTime":"0","summary":"Australia's CSL cuts 2026 earnings forecast as payoff from growth initiatives delayedMay 11  - Australian biotech firm CSL CSL.AX trimmed its fiscal 2026 earnings outlook on Monday, saying the financial benefits will take longer than previously expected to materialise, prompting the firm to revise down its outlook.For fiscal year 2026, CSL now expects a net profit after tax attributable  to be around $3.1 billion on a constant currency basis, compared with $3.3 billion reported a year earlier.   ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260510:nL1N41N065:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7067","CSL.AU","BK7511","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634421709","title":"CSL Ltd - Expects $300 Mln FY26 Revenue Impact From U.S. Immunoglobulin Channel Inventory Normalisation","url":"https://stock-news.laohu8.com/highlight/detail?id=2634421709","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634421709?lang=en_us&edition=fundamental","pubTime":"2026-05-11 06:15","pubTimestamp":1778451324,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260510:nTUE3S3DVB:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7501","BK7508","BK7511","BK7067","CSL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634421702","title":"CSL Ltd-Interim CEO 90 Day Review and Financial Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2634421702","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634421702?lang=en_us&edition=fundamental","pubTime":"2026-05-11 06:15","pubTimestamp":1778451324,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260510:nTUE3S3DVB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7511","BK7508","BK7501","BK7067","CSL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634421701","title":"CSL Ltd - Expects FY26 Revenue of $15.2 Bln and Npata of $3.1 Bln Constant Currency","url":"https://stock-news.laohu8.com/highlight/detail?id=2634421701","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634421701?lang=en_us&edition=fundamental","pubTime":"2026-05-11 06:15","pubTimestamp":1778451324,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260510:nTUE3S3DVB:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","CSL.AU","BK7508","BK7511","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634565448","title":"How CSL’s Share Buyback and Seqirus Demerger Plan Will Impact CSL (ASX:CSL) Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2634565448","media":"Simply Wall St.","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634565448?lang=en_us&edition=fundamental","pubTime":"2026-05-10 07:39","pubTimestamp":1778369992,"startTime":"0","endTime":"0","summary":"CSL Limited recently completed an on‑market buyback and cancelled about 6.4 million ordinary shares, while progressing the planned demerger of its CSL Seqirus influenza vaccine business amid leadership and operational changes.\nThis combination of capital management, portfolio reshaping and executive turnover marks a significant phase of transformation that could reshape how investors assess CSL’s future profile and risks.\nWe’ll now examine how the share cancellation and impending Seqirus...","market":"hk","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/how-csls-share-buyback-and-seqirus-demerger-plan-will-impact","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/how-csls-share-buyback-and-seqirus-demerger-plan-will-impact","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["CSL.AU","SG9999004303.SGD","BK7511","BK7067","BK7501","CSL","BK4086","LU1169590202.USD","LU1169589451.USD","LU0728928796.USD","BK7508","BK4211","ISBC","SGXZ23171101.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634644614","title":"A Look At CSL (ASX:CSL) Valuation After Seqirus Demerger Plan CEO Exit And Ongoing Share Price Weakness","url":"https://stock-news.laohu8.com/highlight/detail?id=2634644614","media":"Simply Wall St.","labels":["executive","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634644614?lang=en_us&edition=fundamental","pubTime":"2026-05-09 03:25","pubTimestamp":1778268328,"startTime":"0","endTime":"0","summary":"Rising interest in CSL (ASX:CSL) has been sparked by a mix of setbacks and corporate moves, including a planned demerger of its CSL Seqirus flu vaccine business, the CEO’s resignation, operational pressures, and ongoing buybacks and dividends.\nSee our latest analysis for CSL.\nAt a recent share price of A$119.88, CSL’s short term share price return has been weak, with a 1 month share price decline of 15.68% and a 90 day share price decline of 33.58%. The 1 year total shareholder return of...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/a-look-at-csl-asxcsl-valuation-after-seqirus-demerger-plan-c","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/a-look-at-csl-asxcsl-valuation-after-seqirus-demerger-plan-c","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive,merge","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0728928796.USD","BK7508","LU1169589451.USD","SG9999004303.SGD","SGXZ23171101.USD","BK7067","LU1169590202.USD","BK4086","BK7511","BK7501","CSL","CSL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633172055","title":"Sprout Social Q1 revenue slightly beats estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2633172055","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633172055?lang=en_us&edition=fundamental","pubTime":"2026-05-08 04:52","pubTimestamp":1778187176,"startTime":"0","endTime":"0","summary":"Sprout Social Q1 revenue slightly beats estimatesOverviewU.S. social media management software firm's Q1 revenue rose 11% yr/yr, slightly beating analyst expectationsCompany announced $50 mln share re","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nL1N41K1KC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4023","SPT","BK7511","BK7067","BK7501","CSL.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131057162","title":"Australian Dollar Reaches Four-Year Peak: Which ASX Stocks Stand to Gain?","url":"https://stock-news.laohu8.com/highlight/detail?id=1131057162","media":"Trading Random","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131057162?lang=en_us&edition=fundamental","pubTime":"2026-05-07 09:51","pubTimestamp":1778118672,"startTime":"0","endTime":"0","summary":"Amidst the constant stream of significant global developments, it can be challenging to monitor shifts within the Australian financial sector. Observant investors, however, will have noticed a major...","market":null,"thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0310799852.SGD","LU0823411888.USD","LU1267930227.SGD","WDS.AU","LU0211328371.USD","BK4597","BK4533","BK4114","BK4017","LU2237443549.SGD","LU2237443382.USD","BK4138","LU1267930490.SGD","BK4076","LU2237443978.SGD","WES.AU","LU1244550221.USD","BK4596","LU1244550577.SGD","LU0310800965.SGD","LU0128525689.USD","COH.AU","BK4532","BK4585","BK4213","BK7142","CSL.AU","BK4156","BK4588","BK4504","JBH.AU","LU1244550494.USD","LU2237443622.USD","WHC.AU","BK4220","LU0052756011.USD","BHP.AU","BK4155","LU0211327993.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632795673","title":"FACTBOX-Global drugmakers rush to boost US presence as tariff threat looms","url":"https://stock-news.laohu8.com/highlight/detail?id=2632795673","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632795673?lang=en_us&edition=fundamental","pubTime":"2026-05-04 21:45","pubTimestamp":1777902351,"startTime":"0","endTime":"0","summary":"FACTBOX-Global drugmakers rush to boost US presence as tariff threat loomsChanges dateline, updates paragraph 1, adds Amgen's investment","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nL4N41H0Y3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1989772840.SGD","LU1267930490.SGD","LU0047473722.EUR","LU1162221912.USD","LU0943347566.SGD","LU1244550221.USD","LU1804176565.USD","LU2750360641.GBP","SG9999017495.SGD","LU0109391861.USD","LU2089283258.USD","BK7067","LU2271345857.HKD","IE00B42XCP33.USD","LU1015430645.USD","IE00BGHQF631.EUR","LU1228905540.USD","LU0316494557.USD","LU0648001328.SGD","IE0005OL40V9.USD","LU0757432116.USD","BK4566","IE00B1XK9C88.USD","LU1153585028.USD","LU0323591593.USD","LU0471298777.SGD","IE00BJJMRX11.SGD","IE000WAW04H5.SGD","JNJ","LU2279689827.SGD","LU0823434583.USD","LU2505996681.GBP","LU1116320901.HKD","IE00BKDWB100.SGD","LU0306806265.USD","LU1261432733.SGD","LU1674673428.USD","SG9999015978.USD","LU0198837287.USD","LU2125909593.SGD","SG9999014542.SGD","LU0965509283.SGD","LU1051770623.HKD","LU0640478417.SGD","LU2539964713.USD","LU0887340254.USD","LU2324357040.USD","LU0432979614.USD","BK4592","LU2023250843.SGD","BK4504","LU0820561909.HKD","LU1623119135.USD","LU0109394709.USD","LU1496350502.SGD","LU0203347892.USD","LU0823434740.USD","LU0823416689.USD","SG9999014898.SGD","IE00BFTCPJ56.SGD","LU0265550359.USD","LU1585245621.USD","LU0708995401.HKD","LU0256863902.USD","LU0289739343.SGD","SG9999013999.USD","LU2430703251.USD","LLYZ","LU1066051811.HKD","IE00B4JS1V06.HKD","LU0256863811.USD","SG9999014914.USD","LU2133065610.SGD","LU2355687059.USD","LU2896262040.SGD","LU2491050154.USD","LU0417517546.SGD","LU0545562505.USD","IE00B7SZLL34.SGD","LU1732799900.SGD","LU0997586432.USD","IE00BJJMRZ35.SGD","LU0070302665.USD","LU1487256676.USD","LU2471134952.CNY","SG9999001440.SGD","LU0889565080.SGD","LU0912757837.SGD","SG9999011175.SGD","LU0545039389.USD","LU2168564222.USD","LU0920840948.USD","IE00B3T34201.USD","BK4585","LU2129689514.USD","SG9999001176.SGD","LU1934455277.USD","LU1720051017.SGD","IE00B7KXQ091.USD","LU1104425308.USD","LU0130102774.USD","LU0980610538.SGD","IE00B894F039.SGD","SGXZ81514606.USD","LU0784385170.HKD","LU1196500208.SGD","IE000SO60NU8.SGD","LU1778281490.HKD","LU1064927863.SGD","LU0353189680.USD","LU0234572021.USD","LU2552382132.HKD","IE00BKVL7J92.USD","LU0526926950.USD","SG9999015986.USD","LU0097036916.USD","LU0128525689.USD","SG9999002232.USD","CSL.AU","LU2471134796.USD","LU0889565916.HKD","LU1894683348.USD","LU0158827781.USD","LU2456880835.USD","LU1267930813.SGD","IE00BVYPNW00.USD","LU0964806797.USD","LU0345777659.USD","LU1718418525.SGD","LU0511384066.AUD","LU0784385840.USD","LU0477156953.USD","LU0942090050.USD","LU0345777147.USD","LU0820562030.AUD","LU2487616109.SGD","SG9999014567.USD","LU2237443622.USD","SG9999014880.SGD","IE00BN29S564.USD","IE00BJJMRY28.SGD","LU0208291251.USD","IE00BLSP4239.USD","LU0210528500.USD","LU0557290698.USD","LU2242652126.USD","LU0170899867.USD","LU2347655156.SGD","LU0211328371.USD","BK4599","LU2265009873.SGD","IE00BKPKM643.USD","LU0158827948.USD","LU2491049909.HKD","LU1481600234.SGD","LU0795875169.SGD","03165","LU0265550946.USD","BK4516","IE0004445015.USD","LU2023250504.SGD","LU0882574139.USD","IE0002141913.USD","LU2237443382.USD","LU0920783379.SGD","IE0000B7K699.USD","LU0289961442.SGD","LU1093756168.USD","LU2746668974.SGD","LU1244550577.SGD","LU0882574055.USD","SGXZ51526630.SGD","LU1019634622.SGD","IE00B4R5TH58.HKD","LU0114720955.EUR","LU0211326755.USD","LU2293690249.USD","LU0784383803.USD","LU1267930573.SGD","LU2112291526.USD","LU0203202063.USD","ELIL","LU2468319806.SGD","LU2129689431.USD","LU0672654240.SGD","IE00BLSP4452.SGD","LU0354030511.USD","LU0321505439.SGD","LU0124676726.USD","LU1883839398.USD","LU2505996509.AUD","LU2237443978.SGD","LU0320765059.SGD","LU1839511570.USD","LU0203201768.USD","BK4550","IE000BZT7R73.USD","LU2237438978.USD","LU1043141123.HKD","LU0553294199.USD","LU2602419157.SGD","LU0456855351.SGD","IE00BFSS8Q28.SGD","BK4568","LU0238689110.USD","LU2028103732.USD","LU0965508806.USD","LU1037948897.HKD","LU2087625088.SGD","IE000F7OJYX1.SGD","IE0009355771.USD","LU1548497426.USD","LU2361044949.HKD","LU1032466523.USD","LU2746668461.USD","LU0171293334.USD","LU1084165304.USD","LU0868494708.USD","LU1035773651.USD","LU2750360997.AUD","BK4007","IE00BWXC8680.SGD","LU0784384876.USD","LU0211327993.USD","LLYX","AZN","BK4532","GB00BDT5M118.USD","LU2430703095.HKD","IE00B19Z3581.USD","LU1868836591.USD","LU2237443895.HKD","LU0689472784.USD","LU1732800096.USD","BK4139","LU1037948541.HKD","LU0972486137.USD","LU0466842654.USD","LU0128525929.USD","LU1074936037.SGD","LU1430594728.SGD","LU0320765489.SGD","LU0354030438.USD","LU1301847155.USD","LU2471134879.HKD","LU2471134523.USD","LU0006306889.USD","IE00B19Z3B42.SGD","LU1046234339.USD","LU0225283273.USD","LU2111349929.HKD","LU2433249047.HKD","LU0133085943.USD","LU1291159041.SGD","LU2360106947.USD","LU1868836757.USD","LU1880407215.USD","LU1019632923.USD","LU0426412945.USD","LU2087621335.USD","LU1551013425.SGD","LU0345770993.USD","SGXZ57979304.SGD","LU2091194634.USD","LU1629891620.HKD","LU2106854487.HKD","LU0390134368.USD","LU0211326839.USD","LU1720051108.HKD","LU1868836914.USD","LU0426417589.USD","LU2089284900.SGD","ABBV","BK7511","LU1043141396.HKD","LU0096364046.USD","LLII","LU2129689605.HKD","LU0985320562.USD","LU0661504455.SGD","SGXZ31699556.SGD","LU0738911758.USD","IE00BFSS7M15.SGD","LU0969580561.USD","LU2168564065.EUR","LU1934455863.HKD","LU1119994496.HKD","LU2168563687.JPY","LU0057025933.USD","LU2461242641.AUD","BK4581","IE00B3PB1722.GBP","AMGN","IE00B775H168.HKD","LU1145028129.USD","LU2756315318.SGD","LU0827474353.SGD","LU0385154629.USD","LU0823399737.USD","LU0306807586.USD","LU0310800965.SGD","LU0499090636.EUR","LU2023250330.USD","LU2293690082.USD","LU1551013342.USD","SG9999018865.SGD","LU2089984988.USD","LU0997586515.USD","LU1280957306.USD","LU2361045086.USD","IE00BJT1NW94.SGD","BK5011","LU0683600562.USD","LU1066053197.SGD","LU2491050071.SGD","LU0786609619.USD","LU1983299246.USD","LU0130517989.USD","LU0053666078.USD","LU1868837136.USD","LU2361044865.SGD","LU2114397693.USD","LU0266013472.USD","LLY","LU0708994859.HKD","LU1267930730.SGD","LU1814569148.SGD","LU1323610961.USD","LU0225771236.USD","LU2211815571.USD","LU2552382215.SGD","LU0077335932.USD","LU1170363599.USD","LU0203345920.USD","IE0034235303.USD","IE00BBT3K403.USD","LU0994945656.USD","SG9999014575.USD","IE00BJLML261.HKD","ELIS","LU0575583348.USD","LU1032955483.USD","LU2168564495.EUR","LU0211331839.USD","IE00BFXG1179.USD","LU0106261372.USD","LU0321505868.SGD","IE00B1BXHZ80.USD","SG9999014559.SGD","LU2213496289.HKD","LU0310800379.SGD","LU2023251221.USD","LU0949170426.SGD","LU1232071149.USD","LU1941712264.USD","BK4578","LU1127390331.HKD","LU2168564149.EUR","IE00BN8TJ469.HKD","LU1121112475.USD","LU1066051225.USD","MRK","LU1481599808.USD","LU2125154935.USD","LU2417539215.USD","BK4559","LU0472753341.HKD","LU1934455194.USD","IE00B2B36J28.USD","LU1496350171.SGD","IE00BVYPNV92.GBP","LU0857590862.USD","GILD","BK4588","LU0320765992.SGD","LU0792757196.USD","LU0689626769.HKD","LU1221951129.SGD","LU0011850046.USD","PFE","SG9999002224.SGD","BK4533","LU1974910355.USD","LU0960981461.USD","LU0289739699.SGD","LU1935042991.SGD","LU0965509010.AUD","LU1003076772.USD","LU2108987350.USD","SG9999014906.USD","IE0034235188.USD","LU1880407132.USD","LU0320765646.SGD","LU2430703178.SGD","LU2125909247.SGD","LU0868494617.USD","SG9999015952.SGD","BK7508","LU0957799991.USD","LU1221951046.USD","SG9999003800.SGD","LU2236285917.USD","LU2592432038.USD","LU0861579265.USD","SG9999015341.SGD","LU0122379950.USD","LU2756315664.SGD","IE00B19Z9Z06.USD","SG9999015358.SGD","LU2357627491.SGD","LU1366192091.USD","SG9999018857.SGD","BK4534","LU1023059063.AUD","LU0058720904.USD","LU2242646821.SGD","BK7501","LU2360032135.SGD","LU1078025761.USD","LU0965509101.SGD","LU1988902786.USD","LU0353189763.USD","IE00B19Z9P08.USD","LU0471298694.HKD","LU1093756325.SGD","LU1506573853.SGD","LU0047473722.SGD","IE000M9KFDE8.USD","LU0949170772.SGD","BIIB","LU2063271972.USD","LU1929549753.HKD","IE00BK4W5M84.HKD","LU0094547139.USD","LU0098860793.USD","LU1153584641.USD","LU1712237335.SGD","LU0310799852.SGD","IE000MB6IJN5.SGD","LU0889566641.SGD","LU1064131342.USD","LU0079474960.USD","IE00BSNM7G36.USD","LU0234570918.USD","LU2125154778.USD","LU1273509221.SGD","LU1228905037.USD","LU0345770308.USD","IE00BKPKM429.USD","LU1059921491.USD","LU0963555726.SGD","IE0004445239.USD","LU1003077747.HKD","LU0795875086.SGD","LU1201861249.SGD","IE0002270589.USD","LU0069063385.USD","IE00BDGV0183.EUR","LU1894683264.USD","LU1674673691.USD","LU0985481810.HKD","LU1069347547.HKD","LU1868837300.USD","LU2264538146.SGD","LU0052756011.USD","LU2237443549.SGD","LU1571399168.USD","LU0976567544.SGD","LU0345769631.USD","LU0496365809.HKD","04332","LU1914381329.SGD","LU0859254822.USD","BK4583","LU1035775433.USD","LU1244550494.USD","LU2357305700.SGD","LU1196032939.SGD","LU2462157665.USD","LU0345769128.USD","LU0640476718.USD","LU0964807845.USD","LU1989772923.USD","LU1699723380.USD","LU1941712348.USD","LU1989771016.USD","IE00BZ1G4Q59.USD","LU1917777945.USD","LU0061475181.USD","LU1267930227.SGD","LU1923622614.USD","LU1066051498.USD","SG9999001176.USD","IE0001KFT4U8.USD","LU1057294990.SGD","LU0029864427.USD","LU1069344957.HKD","IE00BK4W5L77.USD","LU2552382058.USD","LU0787776722.HKD","LU0225284248.USD","LU2237443465.HKD","SG9999015945.SGD","LU0070217475.USD","SGXZ99366536.SGD","LU0210536198.USD","LU1116320737.USD","LU0820561818.USD","LU1061106388.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632987285","title":"Market Chatter: CSL, Resmed, Cochlear Lead Losses on ASX","url":"https://stock-news.laohu8.com/highlight/detail?id=2632987285","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632987285?lang=en_us&edition=fundamental","pubTime":"2026-05-04 11:54","pubTimestamp":1777866873,"startTime":"0","endTime":"0","summary":"CSL  led losses on the Australian bourse so far this year at AU$23.2 billion, while ResMed  and Cochlear  followed with losses of AU$10.6 billion, the Australian Financial Review reported Monday, citing Global X ETFs.Negative performing companies on the S&P/ASX 200 index collectively wiped out over AU$217 billion, said Marc Jocum, senior product and investment strategist at Global X ETFs.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1169589451.USD","BK7067","XJO.AU","CSL","SGXZ23171101.USD","RMD.AU","BK7007","CSL.AU","LU0728928796.USD","BK4086","COH.AU","BK7508","LU1169590202.USD","BK7511","BK7501","SG9999004303.SGD","DBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632621526","title":"Will Restructuring Moves and Seqirus Spin-Off Delay Change CSL's (ASX:CSL) Investment Narrative?","url":"https://stock-news.laohu8.com/highlight/detail?id=2632621526","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632621526?lang=en_us&edition=fundamental","pubTime":"2026-05-02 06:40","pubTimestamp":1777675210,"startTime":"0","endTime":"0","summary":"In recent months CSL has announced workforce reductions, plasma centre closures and delays to the planned Seqirus influenza vaccine spin-off, alongside guidance cuts and ongoing margin pressures that have unsettled investors. \nThis combination of restructuring, margin compression and Seqirus revenue challenges has prompted a reassessment of how durable CSL’s core plasma and vaccine franchises may be. \nWe’ll now examine how margin pressures and the delayed Seqirus spin-off reshape CSL’s...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/will-restructuring-moves-and-seqirus-spin-off-delay-change-c","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/will-restructuring-moves-and-seqirus-spin-off-delay-change-c","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0728928796.USD","BK4585","BK4543","AGIX","BK7067","BK4086","CHAT","CSL.AU","ARTY","BK4588","AIPO","AI","BK4528","CSL","SG9999004303.SGD","AIYY","BK4551","LU1169589451.USD","SGXZ23171101.USD","BK4587","BK7511","BK7501","BK7508","LU1169590202.USD","BK4023"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632675346","title":"A Fresh Look At CSL (ASX:CSL) Valuation After Recent Share Price Weakness","url":"https://stock-news.laohu8.com/highlight/detail?id=2632675346","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632675346?lang=en_us&edition=fundamental","pubTime":"2026-05-01 04:07","pubTimestamp":1777579670,"startTime":"0","endTime":"0","summary":"CSL (ASX:CSL) is back in focus after recent price moves, with the stock down over the month and past 3 months. This has prompted investors to reassess its A$124.37 share price in light of current fundamentals.\nSee our latest analysis for CSL.\nThose recent declines, including a 1 day share price return of 1.12% and a 30 day share price return of 11.66%, sit alongside a 1 year total shareholder return of 49.25%. This suggests momentum has been fading rather than building.\nIf CSL's moves have...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/a-fresh-look-at-csl-asxcsl-valuation-after-recent-share-pric","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/a-fresh-look-at-csl-asxcsl-valuation-after-recent-share-pric","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0728928796.USD","BK7508","LU1169589451.USD","SG9999004303.SGD","SGXZ23171101.USD","BK7067","LU1169590202.USD","BK4086","BK7511","BK7501","CSL","CSL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630371657","title":"CSL Finance Raises INR300 Million Through Allotment of Non-Convertible Debentures","url":"https://stock-news.laohu8.com/highlight/detail?id=2630371657","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630371657?lang=en_us&edition=fundamental","pubTime":"2026-04-28 17:21","pubTimestamp":1777368084,"startTime":"0","endTime":"0","summary":"CSL Finance  has raised 300 million Indian rupees through the allotment of non-convertible debentures on a private placement basis, according to a Tuesday filing to the Indian stock exchanges.The company allotted 30,000 secured, rated, listed, redeemable non-convertible debentures at an issue price of 10,000 rupees each.The debentures carry a coupon rate of 11% and are scheduled to mature on April 20, 2028. They are proposed to be listed on the BSE.The company's shares were down over 1% in recent trade.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CSL.AU","LU0728928796.USD","BK7501","LU1169589451.USD","SG9999004303.SGD","BK7508","BK4086","SGXZ23171101.USD","LU1169590202.USD","BK7511","BK7067","CSL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630874424","title":"Carlisle Companies Q1 Margin Pullback Tests Long Term Expansion Thesis","url":"https://stock-news.laohu8.com/highlight/detail?id=2630874424","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630874424?lang=en_us&edition=fundamental","pubTime":"2026-04-25 13:12","pubTimestamp":1777093945,"startTime":"0","endTime":"0","summary":"Carlisle Companies (CSL) opened 2026 with Q1 revenue of US$1,052.1 million and basic EPS of US$3.13, setting the tone for how the rest of the year might shape up for margin focused investors. Over recent quarters the company has seen revenue move from US$1,095.8 million and EPS of US$3.16 in Q1 2025 to a peak of US$1,449.5 million with EPS of US$5.93 in Q2 2025, before stepping down to US$1,052.1 million and EPS of US$3.13 in the latest quarter as attention shifts firmly to how consistently...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/3061000-choice1-main-header/1585186603448","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/3061000-choice1-main-header/1585186603448"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/capital-goods/nyse-csl/carlisle-companies/news/carlisle-companies-q1-margin-pullback-tests-long-term-expans","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/capital-goods/nyse-csl/carlisle-companies/news/carlisle-companies-q1-margin-pullback-tests-long-term-expans","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7501","BK7508","BK7067","CSL.AU","BK7511","CSL","LU0728928796.USD","LU1169589451.USD","BK4086","LU1169590202.USD","SGXZ23171101.USD","SG9999004303.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629383142","title":"Eurazeo unit Kurma Partners closes Biofund IV at EUR 215 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2629383142","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629383142?lang=en_us&edition=fundamental","pubTime":"2026-04-23 20:34","pubTimestamp":1776947692,"startTime":"0","endTime":"0","summary":"Kurma Partners, Eurazeo group company, closed Biofund IV at EUR 215 million.Fund size rose nearly 35% from EUR 160 million for Biofund III.Cornerstone investors include CSL, European Investment Fund, Bpifrance.Kurma Partners total assets under management reached EUR 1 billion.Biofund IV completed 11 investments, targets about 20.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Eurazeo SE published the original content used to generate this news brief on April 23, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260423:nNDL6Dz3c5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7511","BK7067","BK7501","CSL.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629000490","title":"Australian shares close at two-week low on oil price concerns; Santos jumps over 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629000490","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629000490?lang=en_us&edition=fundamental","pubTime":"2026-04-23 15:04","pubTimestamp":1776927869,"startTime":"0","endTime":"0","summary":"Australian shares close at two-week low on oil price concerns; Santos jumps over 3%Updates to closeMiners down 1%, banks fall 0.7%Santos gains 3.6% NZ 50 drops to three-week lowBy Keshav SinghChundawat","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260423:nL4N4160GL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FMG.AU","LU0971552830.HKD","LU0831103253.SGD","LU0171293334.USD","LU0264606111.USD","LU0612318385.USD","LU1487256676.USD","LU0955623706.USD","RIO.UK","SG9999001143.SGD","LU0788109121.HKD","STO.AU","LU0456854461.SGD","BK7501","BK7511","LU1078025761.USD","BK7067","LU1309081286.SGD","BK7142","LU0572940350.SGD","LU0505663152.USD","LU0345777659.USD","IE00B3M56506.USD","LU0971552673.USD","LU0345780950.USD","LU0898667661.SGD","LU0654597011.USD","LU1430597077.USD","LU1064927863.SGD","LU0955669360.SGD","WDS.AU","LU0955648018.USD","IE00BQJZX424.USD","LU0330918003.SGD","LU0630314457.HKD","BK7129","BK7508","LU0075056555.USD","LU1130305938.SGD","BK5111","LU0572939691.SGD","LU1046248800.SGD","CSL.AU","LU2463526074.USD","LU1481600234.SGD","LU0345777147.USD","LU1302929846.USD","IE00BWDBJ516.SGD","SG9999002521.SGD","LU0011963245.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629019780","title":"BUZZ-Australia's CSL hits 9-year low after US scraps mandatory flu vaccines for military","url":"https://stock-news.laohu8.com/highlight/detail?id=2629019780","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629019780?lang=en_us&edition=fundamental","pubTime":"2026-04-23 13:23","pubTimestamp":1776921818,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's CSL hits 9-year low after US scraps mandatory flu vaccines for military** Shares of CSL Ltd CSL.AX fall as much as 1% to A$127.85, its lowest since Aug 31, 2017** Stock extends previous session's near-6% drop, on track for third straight day of losses** U.S. defense department said on Tuesday that military personnel would no longer be mandated to receive the flu vaccine** Biotech firm is heavily exposed to the U.S., its largest revenue source** Firm's vaccines business, including influenza shots supplied through unit CSL Seqirus, is one of its most profitable divisions** YTD, stock down 25.4%","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260423:nL6N4160BL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSL.AU","BK7501","BK7508","BK7511","BK7067"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":10,"totalSize":200,"code":"91000000","status":"200"}]}}